MidMichigan Medical Center-Midland is a 324-bed, non-profit hospital in Midland, Michigan. It is a member of MidMichigan Health, an integrated health delivery system affiliated with Michigan Medicine, the health care division of the University of Michigan.

There are 324 beds in MidMichigan Medical Center - Midland.

During the past decade, MidMichigan Medical Center - Midland conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 37 clinical trials were completed, i.e. on average, 112.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 20 clinical trials were completed. i.e. 333.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MidMichigan Medical Center - Midland" #1 sponsor was "Radiation Therapy Oncology Group" with 33 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "Abbott Medical Devices" with 5 trials sponsored and "National Cancer Institute (NCI)" with 5 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MidMichigan Medical Center - Midland" #1 collaborator was "National Cancer Institute (NCI)" with 65 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "MidMichigan Medical Center - Midland" are "Breast Cancer" (13 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Head and Neck Cancer" (7 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "MidMichigan Medical Center - Midland" in a lesser frequency.

Most popular intervention types in "MidMichigan Medical Center - Midland" are "Drug" (67 trials), "Radiation" (35 trials), "Other" (29 trials), "Procedure" (20 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (29 trials), "Laboratory Biomarker Analysis" (16 trials), "Placebo" (9 trials), "conventional surgery" (8 trials) and "Quality-of-Life Assessment" (7 trials). Other intervention names were less common.

The vast majority of trials in "MidMichigan Medical Center - Midland" are 70 trials for "All" genders, 17 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "MidMichigan Medical Center - Midland". undefined are not yet recruiting, 3 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in MidMichigan Medical Center - Midland, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in MidMichigan Medical Center - Midland, 7 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 52 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".